# 提出一种基于 PBN-RL-XAI 的框架，用于发现黑色素瘤中的 '打擊和跑' 治療策略

发布时间：2025年07月14日

`Agent` `肿瘤学` `精准医疗`

> A PBN-RL-XAI Framework for Discovering a "Hit-and-Run'' Therapeutic Strategy in Melanoma

# 摘要

> 抗PD-1免疫疗法在转移性黑色素瘤中的固有抵抗性仍是临床上的重大挑战，其分子机制尚不明确。我们通过患者肿瘤活检的转录组数据构建了动态概率布尔网络模型，揭示了治疗反应的调控逻辑。随后，利用强化学习代理系统性地发现最优多步治疗方案，并通过可解释人工智能解析代理的控制策略。研究发现，对赖氨酰氧化酶样蛋白2（LOXL2）进行精准时机的4步临时抑制是最有效策略。分析表明，这种“击中即走”干预可消除耐药性驱动的分子特征，使网络自我修复无需持续干预。本研究提出了一种时间依赖性治疗假说，为克服免疫疗法耐药性提供了新思路，并为在复杂生物系统中识别非显性干预方案提供了强大计算框架。

> Innate resistance to anti-PD-1 immunotherapy remains a major clinical challenge in metastatic melanoma, with the underlying molecular networks being poorly understood. To address this, we constructed a dynamic Probabilistic Boolean Network model using transcriptomic data from patient tumor biopsies to elucidate the regulatory logic governing therapy response. We then employed a reinforcement learning agent to systematically discover optimal, multi-step therapeutic interventions and used explainable artificial intelligence to mechanistically interpret the agent's control policy. The analysis revealed that a precisely timed, 4-step temporary inhibition of the lysyl oxidase like 2 protein (LOXL2) was the most effective strategy. Our explainable analysis showed that this ``hit-and-run" intervention is sufficient to erase the molecular signature driving resistance, allowing the network to self-correct without requiring sustained intervention. This study presents a novel, time-dependent therapeutic hypothesis for overcoming immunotherapy resistance and provides a powerful computational framework for identifying non-obvious intervention protocols in complex biological systems.

[Arxiv](https://arxiv.org/abs/2507.10136)